AngioSoma, Inc. (SOAN) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Houston, TX, 미국. 현재 CEO는 Alex K. Blankenship.
SOAN 을(를) 보유 IPO 날짜 2022-01-31, 에 상장 Other OTC.
AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.
